American Health Ranitidine Tablet Recall [US]

Click to enlarge

US/Silver Spring: American Health Packaging, a Columbus, Ohio establishment, recalls eleven (11) lots of Ranitidine Tablets, USP 150 mg, 100 count Unit Dose Blisters from the American marketplace due to suspected levels of N-Nitrosodimethylamine (“NDMA”), a probable Human Carcinogen, above the allowable limits established by the FDA and consequential risk of Cancer, all serious health hazards.

FDA: http://ht.ly/gFcQ30qnOVO

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/american-health-packaging-issues-voluntary-nationwide-recall-ranitidine-tablets-usp-150-mg-100-count

Additional information:
The US Food and Drug Administration (“FDA”) reports the following prescription drug products are subject to this recall:

Perrigo branded Ranitidine Recall [US]

US/Silver Spring: Perrigo Company plc, an Allegan, Michigan establishment and a subsidiary of Perrigo of Hogan Place, Dublin, Ireland, recalls all current batch/lots and package sizes of Ranitidine, a drug available OTC and by prescription within the United States, due to a specific Nitrosamine contamination called N-nitrosodimethylamine (“NDMA”), a probable human Carcinogen, a substance that could cause Cancer, all serious health hazards.

FDA: http://ht.ly/Msef30pNfyx

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/perrigo-company-plc-issues-voluntary-worldwide-recall-ranitidine-due-possible-presence-impurity-n

Additional information:
The US Food and Drug Administration (“FDA”) reports the following drug products are subject to this recall: